TL
Telix Pharmaceuticals Limited (TLX)
NASDAQ·Healthcare·Biotechnology
$10.04
+1.47%
Mkt Cap $2.54B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (3 analysts)
$19.00
Range $17.00 – $20.00
Implied Upside
+89.2%
Consensus $19.00 vs current $10.04
NASDAQ·Healthcare·Biotechnology
$10.04
+1.47%
Mkt Cap $2.54B
Buy
5
Hold
0
Sell
0
Price Target (3 analysts)
$19.00
Range $17.00 – $20.00
+89.2%
Consensus $19.00 vs current $10.04